Literature DB >> 3926340

Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.

J M Schmitz, P G Apprill, L M Buja, J T Willerson, W B Campbell.   

Abstract

Whereas numerous studies have investigated the role of prostacyclin and thromboxane A2 in the maintenance of coronary blood flow, most of these have focused on normal vessels. In the present investigation, we examined the prostaglandin- and thromboxane-synthesizing capacity of isolated coronary artery segments obtained from the site of a critical coronary artery stenosis. Cyclic flow variations were produced by placing a hard cylindrical constrictor on the proximal left anterior descending coronary artery in open-chest, anesthetized dogs. Cyclic flow variations are characterized by progressive declines in coronary blood flow, interrupted by sudden spontaneous restorations of flow. After cyclic flow variations had been induced, the hearts were removed, and the left anterior descending and circumflex coronary arteries were dissected. The vessels were cut into segments and incubated in the presence of increasing concentrations of arachidonic acid (10(-4)-10(-6) M). The synthesis of prostaglandin E2, thromboxane B2, and 6-keto prostaglandin F1 alpha by the coronary segments was measured by radioimmunoassay. When incubated in the presence of 10(-5) M arachidonic acid, coronary artery segments obtained from the left anterior descending coronary artery undergoing cyclic flow variations produced substantially more thromboxane B2 (142 +/- 27 vs. 29 +/- 3 pg/mg P less than 0.01) and less 6-keto prostaglandin F1alpha (125 +/- 12 vs. 350 +/- 30 pg/mg, P less than 0.01) than control circumflex coronary artery segments. Circumflex coronary vessels in which the endothelium was removed ex vivo produced 6-keto prostaglandin F1alpha levels comparable to those found in the left anterior descending coronary artery (147 +/- 17 pg/mg), but did not synthesize thromboxane B2 (23 +/- 2.6 pg/mg).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926340     DOI: 10.1161/01.res.57.2.223

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.

Authors:  H Matsuno; T Uematsu; K Umemura; Y Takiguchi; K Wada; M Nakashima
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

2.  Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release.

Authors:  Claudie Hecquet; Dauren Biyashev; Fulong Tan; Ervin G Erdös
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-23       Impact factor: 4.733

3.  5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo.

Authors:  F De Clerck; W Loots; Y Somers; J Beetens; L Wouters; J Wynants; P A Janssen
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

4.  The effects of trapidil and propranolol on platelet aggregation and prostacyclin-thromboxane balance following acute myocardial infarction in rabbits.

Authors:  X A Lu; H Ling; C R Dong; J P Ouyang
Journal:  J Tongji Med Univ       Date:  1988

Review 5.  Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.

Authors:  Jun Li; Hanrui Zhang; Cuihua Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-09-05       Impact factor: 5.000

Review 6.  Gene therapy to restore prostacyclin presence to injured endothelium.

Authors:  J T Willerson; P Zoldhelyi; R Meidell; J McNatt; X M Xu; K K Wu
Journal:  Trans Am Clin Climatol Assoc       Date:  1995

Review 7.  Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.

Authors:  J T Willerson
Journal:  Tex Heart Inst J       Date:  1995

8.  Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.

Authors:  M Prosdocimi; A Zatta; M Finesso
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

9.  Effect of complement depletion on O2 supply and consumption in ischemic dog myocardium.

Authors:  G J Grover; H R Weiss
Journal:  Basic Res Cardiol       Date:  1987 Jan-Feb       Impact factor: 17.165

10.  Should all patients with risk factors for ischemic heart disease receive aspirin?

Authors:  J T Willerson; S D Mueller; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.